Most newborns naturally eliminate HPV infections within first six months of life, study finds
- A Canadian study led by Helen Trottier monitored 200 newborns exposed to HPV over two years to assess virus clearance after birth.
- The study followed these infants due to concerns about perinatal HPV transmission, though transmission during pregnancy or childbirth is unlikely.
- The research found nearly all babies eliminated HPV within six months, with only two experiencing recurring infections, defined as a negative test followed by positive later.
- Emra Alice Bnard, the study's lead author, described the findings as highly reassuring, while Trottier highlighted that immunization plays a crucial role in protecting against HPV infection.
- These results suggest low risk of persistent HPV infections in newborns but highlight the importance of adult vaccination to prevent HPV-related cancers.
14 Articles
14 Articles
Most newborns naturally eliminate HPV infections within first six months of life, study finds
Nearly all newborns who contract human papillomavirus in the perinatal stage will eliminate the virus in the first six months of life, with very little persistence or recurrence, according to a new Canadian study published in the Journal of Infectious Disease.
Study bares deep impact of HPV
RESULTS of a recent international study showed that the Philippines was among the countries with the highest burden of cervical cancer due to prevalence of human papillomavirus (HPV). "HPV's Economic Burden: Unmasking the Benefits of HPV Prevention," was conducted by global health economics firm Asc Academics and funded by biopharmaceutical company MSD. It estimated that preventing HPV-related cancers and diseases could save the Philippines $1.3…
HPV infection: prevention and diagnosis
The infection with human papillomavirus, on short HPV, is the main risk factor for the occurrence of uterine cancer. How can this infection be diagnosed, what complications may be given, but how can we prevent HPV infection found by Dr. Laura...
Papillomavirus: a vaccine catch-up recommended for everyone up to 26 years old
The independent public body recommends the extension of the catch-up of HPV vaccination to young men and women, regardless of their sexual orientation and who would not have been vaccinated in adolescence between 11 and 14 years of age, until the age of...
HAS recommends vaccination against human papillomavirus for all up to 26 years
The High Health Authority also recalled that the priority remains the vaccination of adolescents between 11 and 14 years of age. HPV infection is responsible each year for nearly 6,400 new cancer cases.
Coverage Details
Bias Distribution
- 33% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage